ENZO BIOCHEM (UK) Today

Equity ratings for ENZO BIOCHEM INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of July 2022 and ending today, the 8th of August 2022. Click here to learn more.
ENZO BIOCHEM INC cannot be verified against its exchange. It appears ENZO BIOCHEM is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

ENZO BIOCHEM Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. ENZO BIOCHEM's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ENZO BIOCHEM or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ENZO BIOCHEM INC is not yet fully synchronised with the market data
ENZO BIOCHEM INC has some characteristics of a very speculative penny stock
ENZO BIOCHEM INC has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 108.43 M. Net Loss for the year was (4.46 M) with profit before overhead, payroll, taxes, and interest of 48.33 M.
ChairmanElazar Rabbani
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ENZO BIOCHEM's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
ENZO BIOCHEM INC (0IHV) is traded on London Stock Exchange in UK and employs 433 people. The company currently falls under 'Small-Cap' category with current market capitalization of 260.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ENZO BIOCHEM's market, we take the total number of its shares issued and multiply it by ENZO BIOCHEM's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ENZO BIOCHEM INC has 46.51 M outstanding shares. ENZO BIOCHEM INC has accumulated about 62.56 M in cash with 1.21 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check ENZO BIOCHEM Probability Of Bankruptcy

ENZO BIOCHEM Stock Against Markets

Picking the right benchmark for ENZO BIOCHEM stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ENZO BIOCHEM stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ENZO BIOCHEM is critical whether you are bullish or bearish towards ENZO BIOCHEM INC at a given time.
ENZO BIOCHEM INC cannot be verified against its exchange. It appears ENZO BIOCHEM is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

ENZO BIOCHEM Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ENZO BIOCHEM stock to make a market-neutral strategy. Peer analysis of ENZO BIOCHEM could also be used in its relative valuation, which is a method of valuing ENZO BIOCHEM by comparing valuation metrics with similar companies.
American AirlinesAlcoa CorpApple IncBest BuyCitigroupSentinelone IncCVS CorpChevron CorpHome DepotInternational BusinessIntel CorpMetlifeATT IncTarget CorpUnited Parcel Service
 Risk & Return  Correlation

ENZO BIOCHEM Corporate Directors

ENZO BIOCHEM corporate directors refer to members of an ENZO BIOCHEM board of directors. The board of directors generally takes responsibility for the ENZO BIOCHEM's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ENZO BIOCHEM's board members must vote for the resolution. The ENZO BIOCHEM board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Bruce Hanna - Independent DirectorProfile
Gregory Bortz - Lead Independent DirectorProfile
Dov Perlysky - Independent DirectorProfile
Dieter Schapfel - Chief Medical Director, Enzo Clinical LabsProfile

Invested in ENZO BIOCHEM INC?

You need to understand the risk of investing before taking a position in ENZO BIOCHEM. The danger of trading ENZO BIOCHEM INC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ENZO BIOCHEM is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ENZO BIOCHEM. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ENZO BIOCHEM INC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. Note that the ENZO BIOCHEM INC information on this page should be used as a complementary analysis to other ENZO BIOCHEM's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Tools for ENZO BIOCHEM Stock

When running ENZO BIOCHEM INC price analysis, check to measure ENZO BIOCHEM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENZO BIOCHEM is operating at the current time. Most of ENZO BIOCHEM's value examination focuses on studying past and present price action to predict the probability of ENZO BIOCHEM's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ENZO BIOCHEM's price. Additionally, you may evaluate how the addition of ENZO BIOCHEM to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go